9 小时
GlobalData on MSNMaze Therapeutics doses first subject in Phase II AKD treatment trialMaze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...
Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果